Saadia Basharat & Jess Hearn-Messenger Promoted to Principals

Alacrita is delighted to announce that Saadia Basharat, PhD, and Jess Hearn-Messenger, PhD, have both been promoted to Principal.
Learn More

Alacrita offering free mock pitch with managing partner Anthony Walker

Alacrita is offering a free one-hour mock pitch session to biotech startups approaching seed or Series A rounds. Managing partner Anthony Walker, PhD, will be leading these sessions together with at...
Learn More

Alacrita promotes Saadia Basharat, PhD, to Head of West Coast Consulting

Alacrita is pleased to announce the promotion of Saadia Basharat, PhD, to Head of West Coast Consulting.
Learn More

Alastair Southwell promoted to Managing Partner

Alacrita is pleased to announce the promotion of Alastair Southwell to Managing Partner.
Learn More

European Drug Development: A Masterclass

Join Alacrita at the CIC in Kendall Square on January 29th, for an educational session on European drug development and commercialization. You will learn about valuable insight into most challenging...
Learn More

Meet Alacrita at JPM

The Alacrita team will be attending JPM this year in San Francisco. This is always one of the industry's premier annual gatherings. We look forward to seeing many of our partners and colleagues...
Learn More

Alacrita Appoints Peter Traber to Lead Consulting on Anti-fibrotic Drug Development

Alacrita is pleased to announce the appointment of Peter G. Traber, MD, as Partner in its Waltham, MA office. Peter is a distinguished scientist and gastroenterologist/hepatologist with over 30 years...
Learn More

Alacrita Appoints Anna Casse as 4th Managing Partner To Strengthen Commercial Advisory Services and Build a European Launch Platform

Alacrita, the transatlantic life science consulting firm, today announced the appointment of Anna Casse BSc, MBA as Managing Partner. Anna joins Alacrita from BioVault, where she was the CEO,...
Learn More

European Medical Devices Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR)

The final texts of the greatly anticipated European Medical Devices Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR) have just been published in the Official Journal of the European...
Learn More

Alacrita Medical Imaging Consultant Presenting at International Osteoarthritis Conference

Alacrita, the life sciences consulting firm, today announced that medical imaging expert and Alacrita Partner, Colin G Miller PhD, will present a poster at the upcoming Osteoarthritis Research...
Learn More

Edward Garmey MD will moderate a panel at BIO-Europe

On March 20th, Alacrita Partner Edward Garmey, M.D., will moderate a distinguished panel titled “Clinical trials in early stage oncology development” at the 11th annual BIO-Europe Spring conference...
Learn More

Alacrita offers asset scouting services

Alacrita is proud to offer asset scouting services. Please read below to learn about an ongoing project.
Learn More
1 2 3 4 5
Next

Need biotech consulting support? We can help.

Contact us today to learn how our pharma & biotech consulting expertise can serve your project.

Contact us

Explore our biotech & life science consulting services

© 2009-24 Alacrita Holdings Limited  |   Pharma & Biotech Consulting

Alacrita Consulting 
2 Royal College St
London, UK
NW1 0NH

Registered in England & Wales.
No. 10530608


One Broadway
Floor 14
Cambridge, MA 02142

Registered in Massachusetts.